Show simple item record

A concept‐wide association study to identify potential risk factors for nonadherence among prevalent users of antihypertensives

dc.contributor.authorSingh, Karandeep
dc.contributor.authorChoudhry, Niteesh K.
dc.contributor.authorKrumme, Alexis A.
dc.contributor.authorMcKay, Caroline
dc.contributor.authorMcElwee, Newell E.
dc.contributor.authorKimura, Joe
dc.contributor.authorFranklin, Jessica M.
dc.date.accessioned2019-11-12T16:22:13Z
dc.date.availableWITHHELD_12_MONTHS
dc.date.available2019-11-12T16:22:13Z
dc.date.issued2019-10
dc.identifier.citationSingh, Karandeep; Choudhry, Niteesh K.; Krumme, Alexis A.; McKay, Caroline; McElwee, Newell E.; Kimura, Joe; Franklin, Jessica M. (2019). "A concept‐wide association study to identify potential risk factors for nonadherence among prevalent users of antihypertensives." Pharmacoepidemiology and Drug Safety 28(10): 1299-1308.
dc.identifier.issn1053-8569
dc.identifier.issn1099-1557
dc.identifier.urihttps://hdl.handle.net/2027.42/151999
dc.description.abstractPurposeWe sought to determine whether an association study using information contained in clinical notes could identify known and potentially novel risk factors for nonadherence to antihypertensive medications.MethodsWe conducted a retrospective concept‐wide association study (CWAS) using clinical notes to identify potential risk factors for medication nonadherence, adjusting for age, sex, race, baseline blood pressure, estimated glomerular filtration rate, and a combined comorbidity score. Participants included Medicare beneficiaries 65 years and older receiving care at the Harvard Vanguard Medical Associates network from 2010‐2012 and enrolled in a Medicare Advantage program. Concepts were extracted from clinical notes in the year prior to the index prescription date for each patient. We tested associations with the outcome for 5013 concepts extracted from clinical notes in a derivation cohort (4382 patients) and accounted for multiple hypothesis testing by using a false discovery rate threshold of less than 5% (q < .05). We then confirmed the associations in a validation cohort (3836 patients). Medication nonadherence was defined using a proportion of days covered (PDC) threshold less than 0.8 using pharmacy claims data.ResultsWe found 415 concepts associated with nonadherence, which we organized into 11 clusters using a hierarchical clustering approach. Volume depletion and overload, assessment of needs at the point of discharge, mood disorders, neurological disorders, complex coordination of care, and documentation of noncompliance were some of the factors associated with nonadherence.ConclusionsThis approach was successful in identifying previously described and potentially new risk factors for antihypertensive nonadherence using the clinical narrative.
dc.publisherWiley Periodicals, Inc.
dc.subject.otherpharmacoepidemiology
dc.subject.othernonadherence
dc.subject.othermedications
dc.subject.otherhypertension
dc.subject.otherelectronic health record
dc.titleA concept‐wide association study to identify potential risk factors for nonadherence among prevalent users of antihypertensives
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelChemistry
dc.subject.hlbsecondlevelBiological Chemistry
dc.subject.hlbtoplevelHealth Sciences
dc.subject.hlbtoplevelScience
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/151999/1/pds4850.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/151999/2/pds4850_am.pdf
dc.identifier.doi10.1002/pds.4850
dc.identifier.sourcePharmacoepidemiology and Drug Safety
dc.identifier.citedreferenceAronson AR. Effective mapping of biomedical text to the UMLS Metathesaurus: the MetaMap program. Proc AMIA Symp. 2001; 17 ‐ 21. D010001275 [pii]. https://www.ncbi.nlm.nih.gov/pubmed/11825149
dc.identifier.citedreferenceLee KB, Lee J‐Y, Choi N, et al. Association between insufficient medication of antihypertensives and the severity of acute ischemic stroke. Clin Hypertens. 2015; 22 ( 1 ): 11. https://doi.org/10.1186/s40885‐016‐0047‐8
dc.identifier.citedreferenceTong X, Chu EK, Fang J, Wall HK, Ayala C. Nonadherence to antihypertensive medication among hypertensive adults in the United States─HealthStyles, 2010. J Clin Hypertens (Greenwich). 2016; 18 ( 9 ): 892 ‐ 900. https://doi.org/10.1111/jch.12786
dc.identifier.citedreferenceSchmieder RE, Ott C, Schmid A, et al. Adherence to antihypertensive medication in treatment‐resistant hypertension undergoing renal denervation. J Am Heart Assoc. 2016; 5 ( 2 ). https://doi.org/10.1161/JAHA.115.002343
dc.identifier.citedreferenceVan Wijk BL, Klungel OH, Heerdink ER, de Boer A. Rate and determinants of 10‐year persistence with antihypertensive drugs. J Hypertens. 2005; 23 ( 11 ): 2101 ‐ 2107.
dc.identifier.citedreferenceMaeng DD, Snyder RC, Medico CJ, Mold WM, Maneval JE. Unused medications and disposal patterns at home: findings from a Medicare patient survey and claims data. J Am Pharm Assoc (2003). 2016; 56 ( 1 ): 41 ‐ 46.e6. https://doi.org/10.1016/j.japh.2015.11.006
dc.identifier.citedreferenceGellad WF, Grenard J, McGlynn EA.   A Review of Barriers to Medication Adherence: A Framework for Driving Policy Options. 2009.
dc.identifier.citedreferenceGellad WF, Grenard JL, Marcum ZA. A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity. Am J Geriatr Pharmacother. 2011; 9 ( 1 ): 11 ‐ 23. https://doi.org/10.1016/j.amjopharm.2011.02.004
dc.identifier.citedreferenceKrueger KP, Berger BA, Felkey B. Medication adherence and persistence: a comprehensive review. Adv Ther. 2005; 22 ( 4 ): 313 ‐ 356.
dc.identifier.citedreferenceBowry ADK, Shrank WH, Lee JL, Stedman M, Choudhry NK. A systematic review of adherence to cardiovascular medications in resource‐limited settings. J Gen Intern Med. 2011; 26 ( 12 ): 1479 ‐ 1491. https://doi.org/10.1007/s11606‐011‐1825‐3
dc.identifier.citedreferenceMarshall IJ, Wolfe CDA, McKevitt C. Lay perspectives on hypertension and drug adherence: systematic review of qualitative research. BMJ. 2012; 345 ( 1 ): e3953.
dc.identifier.citedreferenceSingh K, Betensky RA, Wright A, Curhan GC, Bates DW, Waikar SS. A concept‐wide association study of clinical notes to discover new predictors of kidney failure. Clin J Am Soc Nephrol. 2016; 11 ( 12 ): 2150 ‐ 2158. https://doi.org/10.2215/CJN.02420316
dc.identifier.citedreferenceFranklin JM, Gopalakrishnan C, Krumme AA, et al. The relative benefits of claims and electronic health record data for predicting medication adherence trajectory. Am Heart J. 2018; 197: 153 ‐ 162. https://doi.org/10.1016/j.ahj.2017.09.019
dc.identifier.citedreferencePatel CJ, Bhattacharya J, Butte AJ. An environment‐wide association study (EWAS) on type 2 diabetes mellitus. PLoS ONE. 2010; 5 ( 5 ): e10746. https://doi.org/10.1371/journal.pone.0010746
dc.identifier.citedreferencePatel CJ, Ioannidis JPA. Studying the elusive environment in large scale. JAMA. 2014; 311 ( 21 ): 2173 ‐ 2174. https://doi.org/10.1001/jama.2014.4129
dc.identifier.citedreferenceDenny JC, Bastarache L, Ritchie MD, et al. Systematic comparison of phenome‐wide association study of electronic medical record data and genome‐wide association study data. Nat Biotechnol. 2013; 31 ( 12 ): 1102 ‐ 1111. https://doi.org/10.1038/nbt.2749
dc.identifier.citedreferenceDeleger L, Molnar K, Savova G, et al. Large‐scale evaluation of automated clinical note de‐identification and its impact on information extraction. J Am Med Inform Assoc. 2013; 20 ( 1 ): 84 ‐ 94. https://doi.org/10.1136/amiajnl‐2012‐001012
dc.identifier.citedreferenceBlackburn DF, Swidrovich J, Lemstra M. Non‐adherence in type 2 diabetes: practical considerations for interpreting the literature. Patient Prefer Adherence. 2013; 7: 183 ‐ 189. https://doi.org/10.2147/PPA.S30613
dc.identifier.citedreferenceChoudhry NK, Glynn RJ, Avorn J, et al. Untangling the relationship between medication adherence and post–myocardial infarction outcomes. Am Heart J. 2014; 167 ( 1 ): 51 ‐ 58.e5. https://doi.org/10.1016/j.ahj.2013.09.014
dc.identifier.citedreferenceTrends in Part C & D Star Rating Measure Cut Points. https://www.cms.gov/medicare/prescription‐drug‐coverage/prescriptiondrugcovgenin/downloads/2014‐trends‐in‐part‐c‐and‐d‐star‐rating‐measure‐cut‐points.Pdf. Accessed April 21, 2017.
dc.identifier.citedreferenceChoudhry NK, Shrank WH, Levin RL, et al. Measuring concurrent adherence to multiple related medications. Am J Manag Care. 2009; 15 ( 7 ): 457 ‐ 464.
dc.identifier.citedreferenceChapman WW, Bridewell W, Hanbury P, Cooper GF, Buchanan BG. A simple algorithm for identifying negated findings and diseases in discharge summaries. J Biomed Inform. 2001; 34 ( 5 ): 301 ‐ 310. https://doi.org/10.1006/jbin.2001.1029
dc.identifier.citedreferenceLevey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009; 150 ( 9 ): 604 ‐ 612. https://doi.org/10.7326/0003‐4819‐150‐9‐200905050‐00006
dc.identifier.citedreferenceGagne JJ, Glynn RJ, Avorn J, Levin R, Schneeweiss S. A combined comorbidity score predicted mortality in elderly patients better than existing scores. J Clin Epidemiol. 2011; 64 ( 7 ): 749 ‐ 759. https://doi.org/10.1016/j.jclinepi.2010.10.004
dc.identifier.citedreferenceGlickman ME, Rao SR, Schultz MR. False discovery rate control is a recommended alternative to Bonferroni‐type adjustments in health studies. J Clin Epidemiol. 2014; 67 ( 8 ): 850 ‐ 857. https://doi.org/10.1016/j.jclinepi.2014.03.012
dc.identifier.citedreferenceStorey JD. The positive false discovery rate: a Bayesian interpretation and the q‐value. Ann Stat. 2003; 31 ( 6 ): 2013 ‐ 2035.
dc.identifier.citedreferenceDesgraupes B. Clustering Indices. https://cran.r‐project.org/web/packages/clusterCrit/vignettes/clusterCrit.pdf. Published 2013. Accessed January 31, 2018.
dc.identifier.citedreferenceBass AJ, Dabney A, Robinson Maintainer John Storey DD. Q‐value estimation for false discovery rate control. http://qvalue.princeton.edu. Published 2016.
dc.identifier.citedreferenceOsterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005; 353 ( 5 ): 487 ‐ 497. https://doi.org/10.1056/NEJMra050100
dc.identifier.citedreferenceCohen DL, Townsend RR. Medication non‐adherence: a bigger problem than physicians assume. J Clin Hypertens (Greenwich). May 2016; 18 ( 9 ): 949 ‐ 950. https://doi.org/10.1111/jch.12838
dc.identifier.citedreferenceMolnar MZ, Gosmanova EO, Sumida K, et al. Predialysis cardiovascular disease medication adherence and mortality after transition to dialysis. Am J Kidney Dis. 2016; 68 ( 4 ): 609 ‐ 618. https://doi.org/10.1053/j.ajkd.2016.02.051
dc.identifier.citedreferenceHerttua K, Martikainen P, Batty GD, Kivimäki M. Poor adherence to statin and antihypertensive therapies as risk factors for fatal stroke. J Am Coll Cardiol. 2016; 67 ( 13 ): 1507 ‐ 1515. https://doi.org/10.1016/j.jacc.2016.01.044
dc.identifier.citedreferenceKim S, Shin DW, Yun JM, et al. Medication adherence and the risk of cardiovascular mortality and hospitalization among patients with newly prescribed antihypertensive medications. Hypertension. 2016; 67 ( 3 ): 506 ‐ 512. https://doi.org/10.1161/HYPERTENSIONAHA.115.06731
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.